AAAAAA
Results: 1-25/35
Authors:
TUBERTBITTER P
HARAMBURU F
BEGAUD B
CHASLERIE A
ABRAHAM E
HAGRY C
Citation: P. Tubertbitter et al., SPONTANEOUS REPORTING OF ADVERSE DRUG-REACTIONS - WHO REPORTS AND WHAT, Pharmacoepidemiology and drug safety, 7(5), 1998, pp. 323-329
Authors:
MOLIMARD M
NALINE E
ZHANG Y
LEGROS V
BEGAUD B
ADVENIER C
Citation: M. Molimard et al., LONG-ACTING AND SHORT-ACTING BETA(2) ADRENOCEPTOR AGONISTS - INTERACTIONS IN HUMAN CONTRACTED BRONCHI, The European respiratory journal, 11(3), 1998, pp. 583-588
Authors:
LAGRANGE F
PEHOURCQ F
BAUMEVIEILLE M
BEGAUD B
Citation: F. Lagrange et al., DETERMINATION OF BUPRENORPHINE IN PLASMA BY LIQUID-CHROMATOGRAPHY - APPLICATION TO HEROIN-DEPENDENT SUBJECTS, Journal of pharmaceutical and biomedical analysis, 16(8), 1998, pp. 1295-1300
Authors:
HAWKEY C
KAHAN A
STEINBRUCK K
ALEGRE C
BAUMELOU E
BEGAUD B
DEQUEKER J
ISOMAKI H
LITTLEJOHN G
MAU J
PAPAZOGLOU S
Citation: C. Hawkey et al., GASTROINTESTINAL TOLERABILITY OF MELOXICAM COMPARED TO DICLOFENAC IN OSTEOARTHRITIS PATIENTS, British journal of rheumatology (Print), 37(9), 1998, pp. 937-945
Authors:
DEQUEKER J
HAWKEY C
KAHAN A
STEINBRUCK K
ALEGRE C
BAUMELOU E
BEGAUD B
ISOMAKI H
LITTLEJOHN G
MAU J
PAPAZOGLOU S
Citation: J. Dequeker et al., IMPROVEMENT IN GASTROINTESTINAL TOLERABILITY OF THE SELECTIVE CYCLOOXYGENASE (COX)-2 INHIBITOR, MELOXICAM, COMPARED WITH PIROXICAM - RESULTS OF THE SAFETY AND EFFICACY LARGE-SCALE EVALUATION OF COX-INHIBITING THERAPIES (SELECT) TRIAL IN OSTEOARTHRITIS, British journal of rheumatology (Print), 37(9), 1998, pp. 946-951
Authors:
HAWKEY C
KAHAN A
STEINBRUCK K
ALEGRE C
BAUMELOU E
BEGAUD B
DEQUER J
ISOMAKI H
LITTLEJOHN G
MAU J
PAPAZOGLOU S
Citation: C. Hawkey et al., GASTROINTESTINAL TOLERABILITY OF MELOXICAM COMPARED TO DICLOFENAC IN OSTEOARTHRITIS PATIENTS (VOL 37, PG 937, 1998), British journal of rheumatology (Print), 37(10), 1998, pp. 1142-1142
Authors:
MOLIMARD M
MOORE N
BEGAUD B
Citation: M. Molimard et al., DOES USE OR WITHDRAWAL OF LONG-ACTING BETA(2)-ADRENOCEPTOR INDUCE DESENSITIZATION, Lancet, 351(9095), 1998, pp. 66-67
Authors:
ALVAREZREQUEJO A
CARVAJAL A
BEGAUD B
MORIDE Y
VEGA T
ARIAS LHM
Citation: A. Alvarezrequejo et al., UNDER-REPORTING OF ADVERSE DRUG-REACTIONS - ESTIMATE BASED ON A SPONTANEOUS REPORTING SCHEME AND A SENTINEL SYSTEM, European Journal of Clinical Pharmacology, 54(6), 1998, pp. 483-488
Authors:
CAPELLA D
LAPORTE JR
VIDAL X
WIHOLM BE
BEGAUD B
LANGMAN MJS
RAWLINS M
Citation: D. Capella et al., EUROPEAN NETWORK FOR THE CASE-POPULATION SURVEILLANCE OF RARE DISEASES (EURONET) - A PROSPECTIVE FEASIBILITY STUDY, European Journal of Clinical Pharmacology, 53(5), 1998, pp. 299-302
Authors:
BAUMEVIEILLE M
HARAMBURU F
BEGAUD B
Citation: M. Baumevieille et al., ABUSE OF PRESCRIPTION MEDICINES IN SOUTHWESTERN FRANCE, The Annals of pharmacotherapy, 31(7-8), 1997, pp. 847-850
Authors:
HEINEMANN LAJ
LEWIS MA
THOROGOOD M
SPITZER WO
GUGGENMOOSHOLZMANN I
BRUPPACHER R
BERGMAN U
BRECKWOLDT M
KEMPER F
LELORIER J
MACLEOD S
MACRAE K
RAY W
SCHLESSELMAN J
CONCIN H
STARK G
PFEIFFER K
WEITGASSER R
BEGAUD B
BOISSEL B
HAERTING J
LAUTENSCHLAEGER F
PUSCHEL K
HOFFMANN F
ROBRA BP
LUSTERMANN M
SCHULZKI I
BOETHIG S
GUTZWILLER F
DECAESTECKER L
MCCOLLUM C
HANNAFORD P
MANN R
KUHLHABICH D
KLINDWORTH C
ASSMANN A
Citation: Laj. Heinemann et al., CASE-CONTROL STUDY OF ORAL-CONTRACEPTIVES AND RISK OF THROMBOEMBOLIC STROKE - RESULTS FROM INTERNATIONAL STUDY ON ORAL-CONTRACEPTIVES AND HEALTH OF YOUNG-WOMEN, BMJ. British medical journal, 315(7121), 1997, pp. 1502-1504
Authors:
MOORE N
KREFTJAIS C
HARAMBURU F
NOBLET C
ANDREJAK M
OLLAGNIER M
BEGAUD B
Citation: N. Moore et al., REPORTS OF HYPOGLYCEMIA ASSOCIATED WITH THE USE OF ACE-INHIBITORS ANDOTHER DRUGS - A CASE NON-CASE STUDY IN THE FRENCH PHARMACOVIGILANCE SYSTEM DATABASE/, British journal of clinical pharmacology, 44(5), 1997, pp. 513-518
Authors:
HARAMBURU F
BEGAUD B
MORIDE Y
Citation: F. Haramburu et al., TEMPORAL TRENDS IN SPONTANEOUS REPORTING OF UNLABELED ADVERSE DRUG-REACTIONS, British journal of clinical pharmacology, 44(3), 1997, pp. 299-301
Authors:
MORIDE Y
HARAMBURU F
REQUEJO AA
BEGAUD B
Citation: Y. Moride et al., UNDER-REPORTING OF ADVERSE DRUG-REACTIONS IN GENERAL-PRACTICE, British journal of clinical pharmacology, 43(2), 1997, pp. 177-181
Authors:
BOISSEL JP
PERRET L
BOUVENOT G
CASTAIGNE A
GERARDCOUE MJ
MAILLERE P
MISMETTI P
VRAY M
AVOUAC B
BEGAUD B
CAULIN C
CHARPAK Y
CHAUMETRIFFAUD P
COSTAGLIOLA D
DEGOS F
DESTORS JM
DOYON F
FAGNANI F
GIRI I
GIRRE JP
GOEHRS JM
KHER A
MOCCATTI D
MUNOZ A
DECURZON AP
PLETAN Y
ROY P
VASMANT D
WAJMAN A
Citation: Jp. Boissel et al., INTERMEDIATE AND SURROGATE OUTCOMES IN CL INICAL-EVALUATION OF DRUGS, Therapie, 52(4), 1997, pp. 281-285
Authors:
ABENHAIM L
RICH S
BENICHOU J
BEGAUD B
Citation: L. Abenhaim et al., APPETITE-SUPPRESSANT DRUGS AND PRIMARY PULMONARY-HYPERTENSION - REPLY, The New England journal of medicine, 336(7), 1997, pp. 512-513
Authors:
FOURRIER A
LETENNEUR L
BEGAUD B
DARTIGUES JF
Citation: A. Fourrier et al., NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE AND COGNITIVE FUNCTION IN THE ELDERLY - INCONCLUSIVE RESULTS FROM A POPULATION-BASED COHORT STUDY, Journal of clinical epidemiology, 49(10), 1996, pp. 1201-1201
Authors:
TUBERTBITTER P
BEGAUD B
MORIDE Y
CHASLERIE A
HARAMBURU F
Citation: P. Tubertbitter et al., COMPARING THE TOXICITY OF 2 DRUGS IN THE FRAMEWORK OF SPONTANEOUS REPORTING - A CONFIDENCE-INTERVAL APPROACH, Journal of clinical epidemiology, 49(1), 1996, pp. 121-123
Authors:
SMITH D
BERNARD N
MORLAT P
BEGAUD B
BEYLOT J
Citation: D. Smith et al., SPARFLOXACIN-RELATED VASCULAR PURPURA, Medecine et maladies infectieuses, 26(5), 1996, pp. 547-548
Authors:
ROSENBERG L
BEGAUD B
BERGMAN U
BROWN B
BUIST AS
CRAMER D
DALING J
GRIMES D
KEMPER F
MILLS A
Citation: L. Rosenberg et al., WHAT ARE THE RISKS OF 3RD-GENERATION ORAL-CONTRACEPTIVES - ARE 3RD-GENERATION ORAL-CONTRACEPTIVES SAFE, Human reproduction, 11(4), 1996, pp. 687-688
Authors:
MERCIE P
RUEFENOUCHE C
FOURNIER A
CONSTANS J
BEGAUD B
CONRI C
Citation: P. Mercie et al., FREQUENCY OF ADVERSE-EFFECTS WITH VASOACT IVE DRUGS IN THE ELDERLY, Therapie, 51(5), 1996, pp. 602-603
Authors:
ABENHAIM L
MORIDE Y
BRENOT F
RICH S
BENICHOU J
KURZ X
HIGENBOTTAM T
OAKLEY C
WOUTERS E
AUBIER M
SIMONNEAU G
BEGAUD B
Citation: L. Abenhaim et al., APPETITE-SUPPRESSANT DRUGS AND THE RISK OF PRIMARY PULMONARY-HYPERTENSION, The New England journal of medicine, 335(9), 1996, pp. 609-616
Authors:
AUTRET E
VASMANT D
BEGAUD B
DUPORTAL HD
BOUTROY MJ
CEZARD JP
DELBOS L
ESCHWEGE E
GOUJARD J
ICHOU F
JACQZAIGRAIN E
KOUZAN S
LASSALE C
LEROY B
OSTINELLI J
PLETAN Y
PONS G
SAUVANET JP
SINGLAS E
TABURET AM
THERENEFENOGLIO MC
TILLEMENT JP
VASSAL G
SAINTSALVY B
Citation: E. Autret et al., DETERMINATION OF DRUG-DOSAGE IN PEDIATRIC S, Therapie, 50(4), 1995, pp. 381-386
Authors:
HARAMBURU F
LINDOULSI T
BAVOUX F
BOYER M
BEGAUD B
BARAT C
MAGNE F
DELAGE F
PERE JC
Citation: F. Haramburu et al., STRATEGY OF TREATMENT OF PRURITUS DURING PREGNANCY, The Annals of pharmacotherapy, 28(1), 1994, pp. 17-20
Authors:
TUBERTBITTER P
BEGAUD B
MORIDE Y
ABENHAIM L
Citation: P. Tubertbitter et al., SAMPLE-SIZE CALCULATIONS FOR SINGLE GROUP POSTMARKETING COHORT STUDIES, Journal of clinical epidemiology, 47(4), 1994, pp. 435-439